A pharmacist‐managed dosing algorithm for darbepoetin alfa and iron sucrose in hemodialysis patients: A randomized, controlled trial
Abstract The attainment of target hemoglobin levels in hemodialysis patients is low. Several factors play a role, such as hyporesponsiveness to erythropoiesis‐stimulating agents (ESA), but also suboptimal prescribing of ESA and iron. The goal of this study was to investigate if a pharmacist‐managed...
Saved in:
Main Authors: | Francisca Johanna van denOever (Author), Carolien F. M. Heetman‐Meijer (Author), Erwin Birnie (Author), Erwin C. Vasbinder (Author), Eleonora L. Swart (Author), Yvonne C. Schrama (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacoeconomic analysis of using the darbepoetin alfa to correct anemia in patients with chronic renal failure who are on hemodialysis or peritoneal dialysis
by: I. S. Krysanov, et al.
Published: (2018) -
Managing chemotherapy induced anemia with darbepoetin alfa and other erythropoiesis stimulating agents: a nurse's perspective
by: Derbyshire L, et al.
Published: (2013) -
Darbepoetin Alfa in Young Infants With Renal Failure: Single Center Experience, a Case Series and Review of the Literature
by: Anna Maria Libudzic-Nowak, et al.
Published: (2018) -
USE OF DARBEPOETIN ALFA (ARANESP®) FOR ANEMIA TREATMENT IN CHILDREN WITH CHRONIC KIDNEY DISEASE - CLINICAL EXPERIENCE OF BULGARIAN PEDIATRIC GROUP
by: Maria Gaydarova, et al.
Published: (2017) -
Effect of occasional epoetin use in combination with a stable darbepoetin dosage on anemia management in hemodialysis patients
by: Shimamatsu K
Published: (2014)